Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?

The Motley Fool · Reuben Gregg Brewer · 2026-11-08 20:15 UTC

Novo Nordisk is looking to build a volume-driven business, but the successful launch of the Wegovy pill is just the first step.

Read the full story at The Motley Fool · All coverage of this story